Cargando…
Suramin-Induced Neurotoxicity: Preclinical Models and Neuroprotective Strategies
Suramin is a trypan blue analogon originally developed to treat protozoan infections, which was found to have diverse antitumor effects. One of the most severe side effects in clinical trials was the development of a peripheral sensory-motor polyneuropathy. In this study, we aimed to investigate sur...
Autores principales: | von der Ahe, David, Huehnchen, Petra, Balkaya, Mustafa, Peruzzaro, Sarah, Endres, Matthias, Boehmerle, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017835/ https://www.ncbi.nlm.nih.gov/pubmed/29414872 http://dx.doi.org/10.3390/molecules23020346 |
Ejemplares similares
-
Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice
por: Boehmerle, Wolfgang, et al.
Publicado: (2014) -
Assessment of Paclitaxel Induced Sensory Polyneuropathy with “Catwalk” Automated Gait Analysis in Mice
por: Huehnchen, Petra, et al.
Publicado: (2013) -
Fingolimod therapy is not effective in a mouse model of spontaneous autoimmune peripheral polyneuropathy
por: Huehnchen, Petra, et al.
Publicado: (2018) -
Blockade of IL-6 signaling prevents paclitaxel-induced neuropathy in C57Bl/6 mice
por: Huehnchen, Petra, et al.
Publicado: (2020) -
Dataset for: Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC)-derived sensory neurons
por: Schinke, Christian, et al.
Publicado: (2021)